当前位置:首页 - 行情中心 - 微芯生物(688321) - 财务分析

微芯生物

(688321)

  

流通市值:94.49亿  总市值:94.49亿
流通股本:4.08亿   总股本:4.08亿

微芯生物(688321)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.51亿元,每股收益-0.13元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益164331.10万元,未分配利润6649.69万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产333814.12万元,负债169483.02万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入481,115,043.66302,160,509.05130,604,180.46523,710,192.86
营业总成本519,910,892.74336,896,673148,782,922.18719,282,373.12
营业利润-44,897,880.57-37,347,379.15-17,665,088.4897,071,775.7
利润总额-44,890,516.29-37,045,788.02-17,119,342.0897,018,888.54
净利润-51,084,939.83-41,006,398.91-18,304,645.5349,187,509.09
其他综合收益-503,438.33368,462.32112,699.581,068,982.28
综合收益总额-51,588,378.16-40,637,936.59-18,191,945.9550,256,491.37
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,098,609,675.591,095,541,975.521,104,076,109.711,130,086,854.54
非流动资产合计2,239,531,491.832,208,965,899.522,109,399,387.152,073,162,574.58
资产总计3,338,141,167.423,304,507,875.043,213,475,496.863,203,249,429.12
流动负债合计380,356,760.29385,631,427.38352,429,362.15390,805,456.29
非流动负债合计1,314,473,443.751,264,615,042.711,171,596,043.151,102,548,100.88
负债合计1,694,830,204.041,650,246,470.091,524,025,405.31,493,353,557.17
归属于母公司股东权益合计1,643,310,963.381,654,261,404.951,689,450,091.561,709,895,871.95
股东权益合计1,643,310,963.381,654,261,404.951,689,450,091.561,709,895,871.95
负债和股东权益合计3,338,141,167.423,304,507,875.043,213,475,496.863,203,249,429.12
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计596,362,199.77374,059,458.6214,740,201.48519,262,417.25
经营活动现金流出小计521,797,905.23358,511,652.89179,312,011.31676,536,051.6
经营活动产生的现金流量净额74,564,294.5415,547,805.7135,428,190.17-157,273,634.35
投资活动现金流入小计1,106,464,509.65782,524,745.18467,099,064.261,170,754,939.89
投资活动现金流出小计1,386,493,392.38930,217,113.75441,629,595.571,545,760,725.33
投资活动产生的现金流量净额-280,028,882.73-147,692,368.5725,469,468.69-375,005,785.44
筹资活动现金流入小计295,000,000213,100,00081,100,000623,094,528.43
筹资活动现金流出小计162,858,074.51146,079,837.5847,686,258.86240,477,124.46
筹资活动产生的现金流量净额132,141,925.4967,020,162.4233,413,741.14382,617,403.97
汇率变动对现金及现金等价物的影响-293,029.62376,569.31163,689.341,083,290.99
现金及现金等价物净增加额-73,615,692.32-64,747,831.1394,475,089.34-148,578,724.83
期末现金及现金等价物余额193,073,646.24201,941,507.43361,164,427.9266,689,338.56
最新报告期:2024-11-07
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
长城证券于夕朦-0.130.050.232024-11-07
海通证券余文心-0.39-0.200.032024-10-30
TOP↑